Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.38
+0.17 (2.36%)
Oct 9, 2026, 12:36 PM EDT - Market open
MRVI Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, MRVI stock has a consensus rating of "Buy" and an average price target of $7.83. The average 1-year stock price forecast is 6.10% higher than the current stock price, while the lowest is $7.00 (-5.15%) and the highest is $9.00 (+21.95%).
Price Target: $7.83 (+6.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MRVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Initiates $9 | Buy | Initiates | $9 | +21.95% | Oct 5, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 16, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Initiates $2.5 → $8 | Hold | Initiates | $2.5 → $8 | +8.40% | Sep 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $8 | Buy | Maintains | $8 | +8.40% | Aug 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $5.5 → $6.5 | Buy | Maintains | $5.5 → $6.5 | -11.92% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
211.77M
from 185.74M
Increased by 14.01%
Revenue Next Year
224.89M
from 211.77M
Increased by 6.20%
EPS This Year
-0.11
from -0.29
EPS Next Year
-0.10
from -0.11
EPS and Forward PE are based on non-GAAP adjusted numbers.